BriaCell Therapeutics Corp. (BCTX)
3.575
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
3.54
-0.04
(-0.98%)
Pre-Market: 20:00
BriaCell Therapeutics Total Assets (Quarterly) : 27.07M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 27.07M |
| January 31, 2026 | 33.59M |
| October 31, 2025 | 13.08M |
| July 31, 2025 | 21.65M |
| April 30, 2025 | 17.00M |
| January 31, 2025 | 9.364M |
| October 31, 2024 | 10.41M |
| July 31, 2024 | 5.872M |
| April 30, 2024 | 6.203M |
| January 31, 2024 | 12.23M |
| October 31, 2023 | 18.62M |
| July 31, 2023 | 27.16M |
| April 30, 2023 | 29.72M |
| January 31, 2023 | 34.16M |
| October 31, 2022 | 38.45M |
| July 31, 2022 | |
| April 30, 2022 | 46.46M |
| January 31, 2022 | 48.55M |
| October 31, 2021 | 56.16M |
| July 31, 2021 | |
| April 30, 2021 | 21.01M |
| January 31, 2021 | 0.4578M |
| October 31, 2020 | 0.4525M |
| July 31, 2020 | 0.479M |
| April 30, 2020 | 0.4394M |
| Date | Value |
|---|---|
| January 31, 2020 | 0.4778M |
| October 31, 2019 | 0.4773M |
| July 31, 2019 | 0.416M |
| April 30, 2019 | 1.199M |
| January 31, 2019 | 0.9386M |
| October 31, 2018 | 1.405M |
| July 31, 2018 | 2.287M |
| April 30, 2018 | 3.716M |
| January 31, 2018 | 0.8014M |
| October 31, 2017 | 1.310M |
| July 31, 2017 | 1.631M |
| April 30, 2017 | 1.588M |
| January 31, 2017 | 1.376M |
| October 31, 2016 | 1.648M |
| July 31, 2016 | 0.8371M |
| April 30, 2016 | 1.216M |
| January 31, 2016 | 0.5988M |
| October 31, 2015 | 0.9778M |
| July 31, 2015 | 1.276M |
| April 30, 2015 | 1.656M |
| January 31, 2015 | 1.776M |
| October 31, 2014 | 2.677M |
| July 31, 2014 | 2.594M |
| April 30, 2014 | 8.148M |
| January 31, 2014 | 8.558M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 12.72M |
| ProMIS Neurosciences, Inc. | 56.69M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.662M |
| Shareholders Equity (Quarterly) | 24.06M |
| Current Ratio | 7.072 |